CETP and coronary artery disorder: The CETP rs708272 polymorphism showed a significantly lower risk for CAD (B1B2+B2B2 vs. B1B1: OR = 0.68, 95 % CI 0.55–0.85, P = 0.0006 and B2B2 vs. B1B1: OR = 0.68, 95 % CI 0.50–0.92, P = 0.012).